Definition (CHV)
|
a kind of antibiotics
|
Definition (CHV)
|
a kind of antibiotics
|
Definition (NCI)
|
A broad-spectrum, macrolide antibiotic with antibacterial activity. Erythromycin diffuses through the bacterial cell membrane and reversibly binds to the 50S subunit of the bacterial ribosome. This prevents bacterial protein synthesis. Erythromycin may be bacteriostatic or bactericidal in action, depending on the concentration of the drug at the site of infection and the susceptibility of the organism involved.
|
Definition (MSH)
|
A bacteriostatic antibiotic macrolide produced by Streptomyces erythreus. Erythromycin A is considered its major active component. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins.
|
Definition (CSP)
|
bacteriostatic antibiotic macrolide produced by Streptomyces erythreus; in sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits; this binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins.
|
Definition (PDQ)
|
A broad-spectrum, topical macrolide antibiotic with antibacterial activity. Erythromycin diffuses through the bacterial cell membrane and reversibly binds to the 50S subunit of the bacterial ribosome. This prevents bacterial protein synthesis. Erythromycin may be bacteriostatic or bactericidal in action, depending on the concentration of the drug at the site of infection and the susceptibility of the organism involved. Check for "http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=39234&idtype=1" active clinical trials or "http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=39234&idtype=1&closed=1" closed clinical trials using this agent. ("http://nciterms.nci.nih.gov:80/NCIBrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C476" NCI Thesaurus)
|
Concepts |
Antibiotic
(T195)
, Organic Chemical
(T109)
|
MSH |
D004917
|
SnomedCT |
332341008, 30427009, 372694001 |
LNC |
LP15115-6, MTHU003043 |
English |
Erythromycin, Erythromycin A, Erythromycin [skin], erythromycin, ERYTHROMYCIN, erythromycin (medication), Erythromycin Base, Erythromycin [Chemical/Ingredient], erythromycins, erythromycin base, Erythromycin [skin] (product), Erythromycin product, Erythromycin (product), Erythromycin (substance), Erythromycin, NOS, Erythromycin [skin] (substance), Erythromycin base, Erythromycins |
Swedish |
Erytromycin
|
Czech |
erythromycin
|
Finnish |
Erytromysiini
|
Italian |
Eritromicina A, Eritromicina |
Russian |
ERITROMITSIN, ЭРИТРОМИЦИН |
Japanese |
エリスロシン(Erythromycin), エリスリット, タカスノン, エリスロマイシン, アイロタイシン |
Croatian |
ERITROMICIN
|
Polish |
Erytromycyna
|
Spanish |
eritromicina (uso dermatológico) (producto), eritromicina (uso dermatológico), eritromicina (piel) (producto), eritromicina (piel), eritromicina (producto), eritromicina (sustancia), eritromicina, Eritromicina |
French |
Érythromycine
|
German |
Erythromycin
|
Portuguese |
Eritromicina
|